Christopher B Brooke

Title: Innovations of Christopher B Brooke

Introduction

Christopher B Brooke is an accomplished inventor based in Champaign, IL. He has made significant contributions to the field of molecular testing, particularly in the context of SARS-CoV-2. With a total of two patents to his name, Brooke's work is paving the way for more accessible and efficient testing methods.

Latest Patents

One of his latest patents focuses on saliva-based molecular testing for SARS-CoV-2. This innovative method bypasses the need for RNA isolation and purification. In experiments involving inactivated SARS-CoV-2 virus spiked into saliva, this testing method has demonstrated a limit of detection of 500-1000 viral particles per mL. This performance rivals that of the standard NP swab method. Initial studies have shown excellent results with 100 clinical samples. The saliva-based process is operationally simple, utilizes readily available materials, and can be easily implemented by existing testing sites. This allows for high-throughput, rapid, and repeat testing of large populations.

Career Highlights

Christopher B Brooke is affiliated with the University of Illinois, where he continues to advance his research and innovations. His work is instrumental in addressing public health challenges, particularly during the ongoing pandemic.

Collaborations

Some of his notable coworkers include Diana Rose Ranoa and Robin L Holland. Their collaborative efforts contribute to the success of the projects they undertake.

Conclusion

Christopher B Brooke's innovative work in saliva-based molecular testing represents a significant advancement in the field of diagnostics. His contributions are vital for improving testing accessibility and efficiency in the fight against infectious diseases.